PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF
The present invention discloses populations of T cells expressing a chimeric antigen receptor (CAR), wherein said T cells are placental T cells derived from cord blood, placental perfusate, or a mixture thereof. Such populations of cells are shown to be improved in a number of aspects over alternati...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JHUN, Kevin LING, Weifang ZELDIS, Jerome, B HE, Shuyang JI, Henry Hongjun HARIRI, Robert J ZHANG, Xiaokui KARASIEWICZ-MENDEZ, Kathy TESS, Kristina GUO, Wenzhong MA, Qiangzhong ZHANG, Yanliang |
| description | The present invention discloses populations of T cells expressing a chimeric antigen receptor (CAR), wherein said T cells are placental T cells derived from cord blood, placental perfusate, or a mixture thereof. Such populations of cells are shown to be improved in a number of aspects over alternative populations of cells such as those derived from peripheral blood mononuclear cell T cells. It also discloses methods of treating cancer, such as a hematologic cancer, e.g., a B cell cancer, or a symptom thereof in a patient in need thereof. These methods omprise administering to the patient an amount of the population of T cells of any one of the invention effective to alleviate the cancer or symptom thereof in the patient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4069258A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4069258A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4069258A13</originalsourceid><addsrcrecordid>eNrjZLAI8HF0dvULcdR1cQ3yDHN1UXD08fF3d_Vz9XRWcHYM0g1RcHb18QlWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASYGZpZGphaOhsZEKAEA7jwnwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF</title><source>esp@cenet</source><creator>JHUN, Kevin ; LING, Weifang ; ZELDIS, Jerome, B ; HE, Shuyang ; JI, Henry Hongjun ; HARIRI, Robert J ; ZHANG, Xiaokui ; KARASIEWICZ-MENDEZ, Kathy ; TESS, Kristina ; GUO, Wenzhong ; MA, Qiangzhong ; ZHANG, Yanliang</creator><creatorcontrib>JHUN, Kevin ; LING, Weifang ; ZELDIS, Jerome, B ; HE, Shuyang ; JI, Henry Hongjun ; HARIRI, Robert J ; ZHANG, Xiaokui ; KARASIEWICZ-MENDEZ, Kathy ; TESS, Kristina ; GUO, Wenzhong ; MA, Qiangzhong ; ZHANG, Yanliang</creatorcontrib><description>The present invention discloses populations of T cells expressing a chimeric antigen receptor (CAR), wherein said T cells are placental T cells derived from cord blood, placental perfusate, or a mixture thereof. Such populations of cells are shown to be improved in a number of aspects over alternative populations of cells such as those derived from peripheral blood mononuclear cell T cells. It also discloses methods of treating cancer, such as a hematologic cancer, e.g., a B cell cancer, or a symptom thereof in a patient in need thereof. These methods omprise administering to the patient an amount of the population of T cells of any one of the invention effective to alleviate the cancer or symptom thereof in the patient.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221012&DB=EPODOC&CC=EP&NR=4069258A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221012&DB=EPODOC&CC=EP&NR=4069258A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JHUN, Kevin</creatorcontrib><creatorcontrib>LING, Weifang</creatorcontrib><creatorcontrib>ZELDIS, Jerome, B</creatorcontrib><creatorcontrib>HE, Shuyang</creatorcontrib><creatorcontrib>JI, Henry Hongjun</creatorcontrib><creatorcontrib>HARIRI, Robert J</creatorcontrib><creatorcontrib>ZHANG, Xiaokui</creatorcontrib><creatorcontrib>KARASIEWICZ-MENDEZ, Kathy</creatorcontrib><creatorcontrib>TESS, Kristina</creatorcontrib><creatorcontrib>GUO, Wenzhong</creatorcontrib><creatorcontrib>MA, Qiangzhong</creatorcontrib><creatorcontrib>ZHANG, Yanliang</creatorcontrib><title>PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF</title><description>The present invention discloses populations of T cells expressing a chimeric antigen receptor (CAR), wherein said T cells are placental T cells derived from cord blood, placental perfusate, or a mixture thereof. Such populations of cells are shown to be improved in a number of aspects over alternative populations of cells such as those derived from peripheral blood mononuclear cell T cells. It also discloses methods of treating cancer, such as a hematologic cancer, e.g., a B cell cancer, or a symptom thereof in a patient in need thereof. These methods omprise administering to the patient an amount of the population of T cells of any one of the invention effective to alleviate the cancer or symptom thereof in the patient.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAI8HF0dvULcdR1cQ3yDHN1UXD08fF3d_Vz9XRWcHYM0g1RcHb18QlWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASYGZpZGphaOhsZEKAEA7jwnwA</recordid><startdate>20221012</startdate><enddate>20221012</enddate><creator>JHUN, Kevin</creator><creator>LING, Weifang</creator><creator>ZELDIS, Jerome, B</creator><creator>HE, Shuyang</creator><creator>JI, Henry Hongjun</creator><creator>HARIRI, Robert J</creator><creator>ZHANG, Xiaokui</creator><creator>KARASIEWICZ-MENDEZ, Kathy</creator><creator>TESS, Kristina</creator><creator>GUO, Wenzhong</creator><creator>MA, Qiangzhong</creator><creator>ZHANG, Yanliang</creator><scope>EVB</scope></search><sort><creationdate>20221012</creationdate><title>PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF</title><author>JHUN, Kevin ; LING, Weifang ; ZELDIS, Jerome, B ; HE, Shuyang ; JI, Henry Hongjun ; HARIRI, Robert J ; ZHANG, Xiaokui ; KARASIEWICZ-MENDEZ, Kathy ; TESS, Kristina ; GUO, Wenzhong ; MA, Qiangzhong ; ZHANG, Yanliang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4069258A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JHUN, Kevin</creatorcontrib><creatorcontrib>LING, Weifang</creatorcontrib><creatorcontrib>ZELDIS, Jerome, B</creatorcontrib><creatorcontrib>HE, Shuyang</creatorcontrib><creatorcontrib>JI, Henry Hongjun</creatorcontrib><creatorcontrib>HARIRI, Robert J</creatorcontrib><creatorcontrib>ZHANG, Xiaokui</creatorcontrib><creatorcontrib>KARASIEWICZ-MENDEZ, Kathy</creatorcontrib><creatorcontrib>TESS, Kristina</creatorcontrib><creatorcontrib>GUO, Wenzhong</creatorcontrib><creatorcontrib>MA, Qiangzhong</creatorcontrib><creatorcontrib>ZHANG, Yanliang</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JHUN, Kevin</au><au>LING, Weifang</au><au>ZELDIS, Jerome, B</au><au>HE, Shuyang</au><au>JI, Henry Hongjun</au><au>HARIRI, Robert J</au><au>ZHANG, Xiaokui</au><au>KARASIEWICZ-MENDEZ, Kathy</au><au>TESS, Kristina</au><au>GUO, Wenzhong</au><au>MA, Qiangzhong</au><au>ZHANG, Yanliang</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF</title><date>2022-10-12</date><risdate>2022</risdate><abstract>The present invention discloses populations of T cells expressing a chimeric antigen receptor (CAR), wherein said T cells are placental T cells derived from cord blood, placental perfusate, or a mixture thereof. Such populations of cells are shown to be improved in a number of aspects over alternative populations of cells such as those derived from peripheral blood mononuclear cell T cells. It also discloses methods of treating cancer, such as a hematologic cancer, e.g., a B cell cancer, or a symptom thereof in a patient in need thereof. These methods omprise administering to the patient an amount of the population of T cells of any one of the invention effective to alleviate the cancer or symptom thereof in the patient.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4069258A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A02%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JHUN,%20Kevin&rft.date=2022-10-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4069258A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |